Biotechnology stocks
1,443 listed biotechnology companies, ordered by market capitalisation, inside the Health Care sector. Every one has a free page with its price history, key figures and Tweenvest factor scores.
| Company | Market cap | Price | Day |
|---|---|---|---|
| OliX Pharmaceuticals, IncKOSDAQ: A226950 | $1.49B | ₩98,100.00 | -12.41% |
| Aktis Oncology, Inc.NasdaqGS: AKTS | $1.47B | $26.49 | -0.08% |
| ORIC Pharmaceuticals, Inc.NasdaqGS: ORIC | $1.47B | $14.10 | -0.70% |
| Ab&B Bio-Tech CO., LTD. JSSEHK: 2627 | $1.47B | HK$— | — |
| Cullinan Therapeutics, Inc.NasdaqGS: CGEM | $1.47B | $22.85 | 0.00% |
| PYC Therapeutics LimitedASX: PYC | $1.46B | AU$2.07 | -3.27% |
| GenFleet Therapeutics (Shanghai) Inc.SEHK: 2595 | $1.46B | HK$30.84 | -3.20% |
| Chongqing Genrix Biopharmaceutical Co., Ltd.SHSE: 688443 | $1.43B | CN¥26.36 | +6.98% |
| Savara Inc.NasdaqGS: SVRA | $1.42B | $5.64 | +0.81% |
| Everest Medicines LimitedSEHK: 1952 | $1.41B | HK$31.44 | +4.11% |
| MoonLake ImmunotherapeuticsNasdaqCM: MLTX | $1.40B | $15.67 | -4.86% |
| Replimune Group, Inc.NasdaqGS: REPL | $1.39B | $16.12 | +9.14% |
| Vor Biopharma Inc.NasdaqGS: VOR | $1.38B | $23.66 | +1.26% |
| MeiraGTx Holdings plcNasdaqGS: MGTX | $1.38B | $14.29 | -0.35% |
| Vitrolife AB (publ)OM: VITR | $1.35B | Skr96.35 | +1.37% |
| Ascletis Pharma Inc.SEHK: 1672 | $1.35B | HK$10.02 | -5.02% |
| Vcanbio Cell & Gene Engineering Corp., LtdSHSE: 600645 | $1.34B | CN¥19.76 | +0.41% |
| MannKind CorporationNasdaqGM: MNKD | $1.32B | $4.08 | -0.24% |
| TenNor Therapeutics (Suzhou) LimitedSEHK: 6872 | $1.31B | HK$199.10 | +0.71% |
| Freenome, Inc.NasdaqCM: FRNM | $1.30B | $11.56 | +3.68% |
| Shanghai OPM Biosciences Co., Ltd.SHSE: 688293 | $1.28B | CN¥61.75 | -6.96% |
| Bio-Thera Solutions, Ltd.SHSE: 688177 | $1.28B | CN¥20.71 | -5.35% |
| Kolon TissueGene, Inc.KOSDAQ: A950160 | $1.27B | ₩20,750.00 | -27.32% |
| Liaoning Chengda Biotechnology Co., Ltd.SHSE: 688739 | $1.27B | CN¥20.68 | -0.86% |
| Shaanxi Micot Pharmaceutical Technology Co., Ltd.SEHK: 2335 | $1.25B | HK$29.66 | +2.21% |
| Aimed Bio Inc.KOSDAQ: A0009K0 | $1.25B | ₩27,250.00 | +3.02% |
| Sana Biotechnology, Inc.NasdaqGS: SANA | $1.25B | $4.13 | -0.72% |
| Corvus Pharmaceuticals, Inc.NasdaqGM: CRVS | $1.24B | $15.07 | +2.31% |
| Monte Rosa Therapeutics, Inc.NasdaqGS: GLUE | $1.23B | $14.44 | +0.42% |
| BioGaia AB (publ)OM: BIOG B | $1.23B | Skr115.50 | -1.37% |
| Immatics N.V.NasdaqCM: IMTX | $1.22B | $9.30 | +4.14% |
| Daan Gene Co., Ltd.SZSE: 002030 | $1.17B | CN¥5.60 | -2.95% |
| Kura Oncology, Inc.NasdaqGS: KURA | $1.16B | $13.30 | +1.84% |
| GNI Group Ltd.TSE: 2160 | $1.15B | ¥2,786.00 | -5.08% |
| Suzhou Ribo Life Science Co., Ltd.SEHK: 6938 | $1.15B | HK$52.90 | +0.67% |
| China Resources Boya Bio-pharmaceutical Group Co.,LtdSZSE: 300294 | $1.14B | CN¥15.18 | -2.75% |
| LongBio Pharma (Suzhou) Co., Ltd.SEHK: 1779 | $1.13B | HK$120.00 | +0.50% |
| Frontier Biotechnologies Inc.SHSE: 688221 | $1.11B | CN¥20.00 | -8.97% |
| Inventiva S.A.ENXTPA: IVA | $1.11B | €4.02 | +3.61% |
| Philogen S.p.A.BIT: PHIL | $1.11B | €23.25 | -1.27% |
| NatureCell Co.,Ltd.KOSDAQ: A007390 | $1.10B | ₩23,750.00 | +1.50% |
| Avalo Therapeutics, Inc.NasdaqCM: AVTX | $1.10B | $20.22 | -1.61% |
| CStone PharmaceuticalsSEHK: 2616 | $1.10B | HK$5.39 | -6.27% |
| Chengdu Kanghua Biological Products Co., Ltd.SZSE: 300841 | $1.09B | CN¥56.50 | +15.68% |
| Amoy Diagnostics Co., Ltd.SZSE: 300685 | $1.09B | CN¥18.99 | -2.76% |
| Beijing SL Pharmaceutical Co., Ltd.SZSE: 002038 | $1.08B | CN¥7.08 | +17.22% |
| Changchun BCHT Biotechnology Co.SHSE: 688276 | $1.07B | CN¥17.36 | +8.70% |
| Kuros Biosciences AGSWX: KURN | $1.07B | CHF21.52 | 0.00% |
| Janux Therapeutics, Inc.NasdaqGM: JANX | $1.06B | $18.97 | +9.06% |
| Orum Therapeutics, Inc.KOSDAQ: A475830 | $1.05B | ₩68,100.00 | -2.58% |
| Jiangsu Aidea Pharmaceutical Group Co., Ltd.SHSE: 688488 | $1.03B | CN¥16.49 | -9.15% |
| Arbutus Biopharma CorporationNasdaqGS: ABUS | $1.03B | $5.18 | -0.29% |
| Beijing Strong Biotechnologies,Inc.SZSE: 300406 | $1.02B | CN¥11.70 | -3.15% |
| Alphamab OncologySEHK: 9966 | $1.01B | HK$8.18 | +0.37% |
| GC Biopharma Corp.KOSE: A006280 | $1.01B | ₩122,100.00 | -5.50% |
| Candel Therapeutics, Inc.NasdaqGM: CADL | $1.00B | $13.80 | +5.10% |
| Seegene, Inc.KOSDAQ: A096530 | $1.00B | ₩30,500.00 | -5.13% |
| TLC BioSciences Corp.TPEX: 7924 | $1.00B | NT$240.00 | +11.11% |
| Basilea Pharmaceutica AGSWX: BSLN | $999.67M | CHF65.40 | +1.24% |
| Solid Biosciences Inc.NasdaqGS: SLDB | $997.19M | $10.11 | +8.71% |
| Odyssey Therapeutics, Inc.NasdaqCM: ODTX | $993.35M | $25.67 | +23.83% |
| Climb Bio, Inc.NasdaqGM: CLYM | $992.50M | $15.54 | -10.07% |
| L&C BIO Co.,LTDKOSDAQ: A290650 | $992.47M | ₩51,000.00 | -6.76% |
| Geron CorporationNasdaqGS: GERN | $982.98M | $1.53 | 0.00% |
| Immix Biopharma, Inc.NasdaqCM: IMMX | $977.23M | $14.42 | +5.56% |
| Design Therapeutics, Inc.NasdaqGS: DSGN | $975.65M | $15.45 | -0.90% |
| Abbisko Cayman LimitedSEHK: 2256 | $962.29M | HK$10.54 | -2.59% |
| CARsgen Therapeutics Holdings LimitedSEHK: 2171 | $958.27M | HK$13.36 | +1.14% |
| Ardelyx, Inc.NasdaqGM: ARDX | $954.39M | $3.83 | 0.00% |
| HOB Biotech Group Corp.,LtdSHSE: 688656 | $948.98M | CN¥101.78 | +9.26% |
| Annexon, Inc.NasdaqGS: ANNX | $946.00M | $5.09 | +2.00% |
| Olema Pharmaceuticals, Inc.NasdaqGS: OLMA | $935.35M | $10.87 | +1.68% |
| Shanghai Haohai Biological Technology Co., Ltd.SEHK: 6826 | $924.64M | HK$16.50 | +0.06% |
| Lepu Biopharma Co., Ltd.SEHK: 2157 | $909.12M | HK$3.95 | -11.93% |
| PeptiDream Inc.TSE: 4587 | $894.25M | ¥1,108.50 | -0.49% |
| Hangzhou Biotest Biotech Co.,Ltd.SHSE: 688767 | $886.33M | CN¥40.72 | -2.58% |
| Rigel Pharmaceuticals, Inc.NasdaqGS: RIGL | $868.24M | $46.91 | +0.93% |
| Oxford Biomedica plcLSE: OXB | $867.76M | £5.27 | +0.19% |
| DBV Technologies S.A.ENXTPA: DBV | $862.94M | €2.50 | +5.58% |
| 4D Molecular Therapeutics, Inc.NasdaqGS: FDMT | $859.60M | $15.24 | -2.09% |
| JS Link, Inc.KOSDAQ: A127120 | $852.59M | ₩34,000.00 | -16.05% |
| Genfit S.A.ENXTPA: GNFT | $842.11M | €14.52 | +0.69% |
| Pharming Group N.V.ENXTAM: PHARM | $839.49M | €1.02 | +2.23% |
| Faeth Therapeutics, Inc.NasdaqCM: FTH | $826.89M | $32.82 | +2.56% |
| Achieve Life Sciences, Inc.NasdaqCM: ACHV | $822.19M | $8.33 | +4.26% |
| Aura Biosciences, Inc.NasdaqGM: AURA | $801.64M | $7.79 | +0.78% |
| Silence Therapeutics plcNasdaqGM: SLN | $798.98M | $13.61 | +2.56% |
| ChemPartner PharmaTech Co.,Ltd.SZSE: 300149 | $768.90M | CN¥10.38 | -7.32% |
| Neurogene Inc.NasdaqGM: NGNE | $768.64M | $38.80 | +1.02% |
| Bright Minds Biosciences Inc.CNSX: DRUG | $762.98M | CA$105.26 | -1.94% |
| Shattuck Labs, Inc.NasdaqGS: STTK | $755.74M | $7.80 | +3.59% |
| CK Life Sciences Int'l., (Holdings) Inc.SEHK: 775 | $741.67M | HK$0.61 | +11.01% |
| Crescent Biopharma, Inc.NasdaqCM: CBIO | $733.61M | $18.06 | +5.37% |
| Qurient Co., Ltd.KOSDAQ: A115180 | $727.68M | ₩24,800.00 | -3.13% |
| BridgeBio Oncology Therapeutics, Inc.NasdaqGM: BBOT | $725.77M | $9.17 | +1.21% |
| CytomX Therapeutics, Inc.NasdaqGS: CTMX | $723.43M | $3.36 | +1.05% |
| Monopar Therapeutics Inc.NasdaqCM: MNPR | $723.04M | $114.37 | +6.17% |
| Assembly Biosciences, Inc.NasdaqGS: ASMB | $721.17M | $35.20 | -0.62% |
| Novoprotein Scientific Inc.SHSE: 688137 | $718.50M | CN¥69.58 | +48.93% |
| Shenzhen Weiguang Biological Products Co., Ltd.SZSE: 002880 | $712.55M | CN¥21.12 | +2.67% |